Within the past few years, new treatments have begun to turn the tide against metastatic melanoma, improving and even saving the lives of countless people with this deadly disease.
Sep 11, 2015
0
16
A single stem cell has the potential to generate an animal made of millions of different types of cells. Some cancers contain stem-like but abnormal cells that can act like mini factories to rapidly churn out not only more ...
Sep 10, 2015
0
161
Duke researchers made a big splash in the news last spring when 60 Minutes featured the success of early clinical trials using a modified poliovirus in the fight against a deadly form of brain cancer. Now, with funding from ...
Aug 27, 2015
0
47
Scientists at the Johns Hopkins Kimmel Cancer Center have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease spreads—metastasizes—in some cases. Their findings reveal ...
Aug 10, 2015
0
27
A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
Aug 10, 2015
0
16
In the spring of 2012, Tom Stutz was a man without a future. Just getting through the day took all of his energy and determination.
Jun 29, 2015
0
175
The ability to track and observe live cells in the body has offered unprecedented opportunities to the scientific community to understand key biological processes. Until now, reporter systems to track cells, especially in ...
Jun 10, 2015
0
23
A novel molecular imaging technology not only detects prostate cancer that has spread throughout the body, but also provides a potent and minimally invasive method of radiotherapy, reveal researchers at the 2015 Society of ...
Jun 8, 2015
0
7
A novel radionuclide drug tackles the challenge of prostate cancer imaging and takes a turn as a cancer-killing therapy for tumors in and out of the prostate, according to research presented during the 2015 Annual Meeting ...
Jun 8, 2015
0
212
Cleveland: Cleveland Clinic researchers have discovered for the first time that a metabolite of an FDA-approved drug for metastatic prostate cancer, abiraterone (Abi), has more anti-cancer properties than its precursor. The ...
Jun 1, 2015
0
30
